Purchase Order 75N93024P01193

Award Date 9/20/24
Potential Completion Date 11/19/24
Potential Value $4.1M
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20814, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $550,885.74 firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for the purchase of one BD FACSymphony A5 SE Cell Analyzer system. The system will include the components listed in the attached bill of materials to the original solicitation and must meet technical requirements to detect up to 60...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $348,885.85 firm fixed price purchase order to Becton, Dickinson And Company (BD) for a BD Bioscience LSR Fortessa flow cytometer system, which is cell analysis equipment used for examining data from samples. This was not a set-aside contract. BD is a global medical technology company that provides instruments, reagents, and services supporting biomedical...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order to Becton, Dickinson and Company (BD) for one BD FACSymphony A3 Cell Analyzer with 5 laser configurations valued at $327,752.50. This equipment will replace an existing BD LSRII flow cytometer to support ongoing research projects at the NIAID Laboratory of Immune System Biology. The contract was awarded on...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS NIH NIAID) awarded a 1-year $130,085.64 firm fixed price purchase order to Becton, Dickinson and Company (BD) for a service agreement to maintain BD Biosciences flow cytometry instruments at the NIAID Vaccine Research Center in Gaithersburg, MD. The solicitation was competed on an unrestricted full and open basis with no set-aside. BD, a global medical technology...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $719,435 firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for the delivery of one BD FACSymphony S6 Cell Sorter system. The system will meet requirements specified in the solicitation including the ability to simultaneously detect 50 parameters and sort clustered cell populations. It will be...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a one-year, firm-fixed-price purchase order worth $148,338.00 to Becton, Dickinson and Company (BD) for a service agreement to maintain two BD Biosciences S6 cell sorters and associated lasers at the Vaccine Research Center facility. The award was made on a full and open competition basis without a small business set-aside. BD, a global medical technology...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $73,666.80 firm fixed price purchase order to Becton, Dickinson and Company (BD) for a service contract to provide a FACSymphony S6 cell sorter and 5 various lasers. This contract does not have a set-aside designation. BD is a global medical technology company that develops, manufactures, and sells medical supplies, instruments, laboratory equipment, and diagnostic products. The company has extensive experience...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order contract to Becton, Dickinson and Company (BD) for the supply of one FACSymphony A5 SORP & Fortessa System cell analyzer, valued at $574,988.05. The contract has no set-aside designation. BD is a global medical technology company that provides a wide range of equipment, reagents, and services to support biomedical research...
This is a $71,725 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Becton, Dickinson and Company (BD) for a specialized laser option for a flow cytometry instrument. The award has no set-aside designation. BD is a global medical technology company that provides a wide range of instruments, reagents, and services to support biomedical research and clinical applications, including extensive contracts with federal healthcare agencies...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to Becton, Dickinson and Company (BD) for the procurement of a BD LSRFortessa Cell Analysis System, including a FACS flow supply system and various lasers. The $699,703.08 contract was awarded on a sole-source basis, as BD was determined to be the only source capable of providing the required equipment. The contract was...

The National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center (VRC), Flow Cytometry Core Facility (FCC) awarded a $4,078,219.52 firm-fixed-price purchase order to Becton, Dickinson And Company (BD) to acquire eight cell analyzers. The cell analyzers are needed to maintain continuity of science, data integrity, and experimental compatibility between existing equipment and critical protocols at the NIH Bethesda campus. The requirement was competed as a brand name or equal solicitation under Simplified Acquisition Procedures with no set-aside designation. BD, a global medical technology company and manufacturer of goods, was selected based on technical acceptability, price, and past performance. The cell analyzers will support the VRC's mission to discover and develop novel vaccines and biologics targeting infectious diseases of global public health importance.

Generated 10/1/24, 10:50 AM